年単位の研究成果
Fingerprint Ichiro Kawadaが取り組む研究トピックをご確認ください。これらのトピックラベルは、この人物の研究に基づいています。これらを共に使用することで、固有の認識が可能になります。
- 15 同様のプロファイル
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Lung Neoplasms
Medicine & Life Sciences
Protein-Tyrosine Kinases
Medicine & Life Sciences
Epidermal Growth Factor Receptor
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
irinotecan
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
ネットワーク
最近の共同研究。丸をクリックして詳細を確認しましょう。
研究成果 2000 2019
- 518 引用
- 13 h指数
- 41 Article
Disseminated histoplasmosis from a calcified lung nodule after long-term corticosteroid therapy in an elderly Japanese patient: A case report
Kobayashi, K., Asakura, T., Kawada, I., Hasegawa, H., Chubachi, S., Ohara, K., Kuramoto, J., Sugiura, H., Fujishima, S., Iwata, S., Umeyama, T., Katano, H., Uwamino, Y., Miyazaki, Y., Kamei, K., Hasegawa, N. & Betsuyaku, T., 2019 4 1, ： : Medicine. 98, 17, p. e15264研究成果: Article
公開
Histoplasmosis
Adrenal Cortex Hormones
Lung
Fever
meropenem
6
引用
(Scopus)
Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations
Hasegawa, H., Yasuda, H., Hamamoto, J., Masuzawa, K., Tani, T., Nukaga, S., Hirano, T., Kobayashi, K., Manabe, T., Terai, H., Ikemura, S., Kawada, I., Naoki, K. & Soejima, K., 2019 1 1, ： : Lung Cancer. 127, p. 146-152 7 p.研究成果: Article
Insertional Mutagenesis
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Exons
Therapeutics
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations
Ikemura, S., Yasuda, H., Matsumoto, S., Kamada, M., Hamamoto, J., Masuzawa, K., Kobayashi, K., Manabe, T., Arai, D., Nakachi, I., Kawada, I., Ishioka, K., Nakamura, M., Namkoong, H., Naoki, K., Ono, F., Araki, M., Kanada, R., Ma, B., Hayashi, Y. および8人, , 2019 5 14, ： : Proceedings of the National Academy of Sciences of the United States of America. 116, 20, p. 10025-10030 6 p.研究成果: Article
公開
Molecular Dynamics Simulation
Lung Neoplasms
Mutation
Pharmaceutical Preparations
Protein-Tyrosine Kinases
Monomer preference of EGFR tyrosine kinase inhibitors influences the synergistic efficacy of combination therapy with cetuximab
Oashi, A., Yasuda, H., Kobayashi, K., Tani, T., Hamamoto, J., Masuzawa, K., Manabe, T., Terai, H., Ikemura, S., Kawada, I., Naoki, K. & Soejima, K., 2019 1 1, ： : Molecular cancer therapeutics. 18, 9, p. 1593-1601 9 p.研究成果: Article
Dimerization
Protein-Tyrosine Kinases
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Therapeutics
3
引用
(Scopus)
Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer
Kobayashi, K., Naoki, K., Manabe, T., Masuzawa, K., Hasegawa, H., Yasuda, H., Kawada, I., Soejima, K. & Betsuyaku, T., 2018 6 6, ： : OncoTargets and Therapy. 11, p. 3335-3343 9 p.研究成果: Article
Non-Small Cell Lung Carcinoma
Biopsy
Mutation
Serum
Neoplasms